Sonographic characteristics of local soft tissue recurrence in primary bone tumor and diagnostic efficacy versus MRI

原发性骨肿瘤局部软组织复发的超声特征及其与MRI的诊断效能比较

阅读:1

Abstract

BACKGROUND: The accurate diagnosis of local soft tissue recurrence (LR) in primary bone tumors is crucial for guiding clinical management and predicting patient outcomes. However, standardized postoperative surveillance protocols remain undefined. This study aims to compare the diagnostic efficacy of ultrasound (US) versus magnetic resonance imaging (MRI) in detecting LR following primary bone tumor surgery and to characterize the sonographic features of osteosarcoma recurrence. METHODS: We conducted a retrospective review of medical records from patients who underwent postoperative surveillance for primary bone tumors at our institution between 01/06/2016 to 01/09/2023. Diagnostic performance was compared using McNemar's test for paired variables. Sonographic characteristics were analyzed using logistic regression analysis, with statistical significance set at p < 0.05. RESULTS: Comparative analysis revealed no statistically significant differences (p > 0.05) in sensitivity, specificity, or accuracy between MRI and US, and the exact values for these parameters are provided in Table 1. Key sonographic features predictive of osteosarcoma recurrence included tumor size and anatomical location. The diagnostic model demonstrated excellent discriminative ability, with an area under the receiver operating characteristic (ROC) curve of 0.973. The diagnostic parameters were as follows: sensitivity (96.6%), specificity (90.9%), accuracy (94.6%), positive predictive value (95.0%), and negative predictive value (93.8%). CONCLUSION: The findings from this study support the role of ultrasonography as a valuable tool in tumor surveillance paradigms, providing a scientific rationale for optimizing integrated management strategies in bone oncology.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。